Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article

This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis

Highly Access

B cells in rheumatoid synovitis

Cornelia M Weyand*, Thorsten M Seyler and Jörg J Goronzy

Arthritis Research & Therapy 2005, 7(Suppl 3):S9-S12 doi:10.1186/ar1737

Accesses  

  • Last 30 days: 54 accesses
  • Last 365 days: 516 accesses
  • All time: 5797 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access

Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial

Brinda Emu, Diana Luca, Carolyn Offutt, Jane L Grogan, Bernadette Rojkovich, Marna B Williams, Meina T Tang, Jim Xiao, June H Lee, John C Davis Arthritis Research & Therapy 2012, 14:R6 (8 January 2012)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane

René Huber, Christian Hummert, Ulrike Gausmann, Dirk Pohlers, Dirk Koczan, Reinhard Guthke, Raimund W Kinne Arthritis Research & Therapy 2008, 10:R98 (22 August 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

PubMed Central: View citations